FDA.reportPublic FDA data

OCTREOTIDE ACETATE - Food and Drug Administration

Manufacturer
Food and Drug Administration
Effective date
2020-06-16
Label type
Indexing - product concept
Version
1
Source
full-release
Hydrated at
2026-06-05 00:19:03

Label at a glance#

ProductOCTREOTIDE ACETATE
Active ingredientOCTREOTIDE ACETATE

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
OCTREOTIDE ACETATE75R0U2568IACTIM

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SandostatinOCTREOTIDE ACETATENovartis Pharmaceuticals Corporation4e2c9856-1836-49f0-9472-4dbeeb408f392026-07-22Warnings, Adverse reactionsName fallback
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATEGLENMARK PHARMACEUTICALS INC., USA387d7f8d-9762-4f6b-99e1-bdc50b8a16332026-01-30Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
OCTREOTIDE ACETATEOCTREOTIDE ACETATEMylan Institutional LLCe5c21813-4714-4f23-be8b-765bd58f63b32026-01-21Warnings, Adverse reactionsName fallback
brand name: OCTREOTIDE ACETATE
generic name: OCTREOTIDE ACETATE
Sandostatin LAR DepotOCTREOTIDE ACETATENovartis Pharmaceuticals Corporationd0b7fe9e-7000-4b79-ba3b-291ce92c14f92025-12-22Warnings, Adverse reactionsName fallback
generic name: OCTREOTIDE ACETATE
OCTREOTIDE ACETATEOCTREOTIDE ACETATEHainan Shuangcheng Pharmaceuticals Co., Ltd.ab9b0d3d-4dab-4c5b-9c23-3a14f8fcfcde2025-06-25Warnings, Adverse reactionsName fallback
brand name: OCTREOTIDE ACETATE
generic name: OCTREOTIDE ACETATE
BYNFEZIA PenOCTREOTIDE ACETATESun Pharmaceutical Industries, Inc.20ed4e79-ad4c-426f-859d-83790c00439b2025-02-21Warnings, Adverse reactionsName fallback
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATEMeitheal Pharmaceuticals, Inc.01962c67-e551-47b6-a276-e1ae1860d2a42025-01-16Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
OCTREOTIDE ACETATEOCTREOTIDE ACETATEHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.ffaf9462-cdd8-433b-8b03-464a35577fe92024-12-03Warnings, Adverse reactionsName fallback
brand name: OCTREOTIDE ACETATE
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATETeva Pharmaceuticals, Inc.d9739ea6-74de-4a41-a806-6e827a23cedb2024-07-30Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATEGland Pharma Limited884e4287-a4d8-4a6e-8d99-dbe5e88875b92024-07-29Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATEGland Pharma Limited2344ae7a-c2f0-433b-9133-1dcb16bb18a02024-07-25Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
Octreotide AcetateOCTREOTIDE ACETATEMylan Institutional LLC2d78d5d1-77b2-4da1-98d4-d9c36e743ce22024-07-15Warnings, Adverse reactionsName fallback
brand name: Octreotide Acetate
generic name: OCTREOTIDE ACETATE
OctreotideOCTREOTIDE ACETATEFresenius Kabi USA, LLCd6a9a800-889d-417f-b533-1913197d00222024-05-23Warnings, Adverse reactionsName fallback
generic name: OCTREOTIDE ACETATE
OctreotideOCTREOTIDE ACETATEFresenius Kabi USA, LLCf278f0d8-4062-420a-97c3-3a8b88253a082024-05-07Warnings, Adverse reactionsName fallback
generic name: OCTREOTIDE ACETATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.